ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A novel inflammation-associated prognostic signature for clear cell renal cell carcinoma

Liu, Gangcheng; Xiong, Donglan; Che, Zhifei; Chen, Hualei*; Jin, Wenyi*海南医学院; 武汉大学; 1
Oncology Letters2022-9DOI: 10.3892/ol.2022.13427
10被引6阅读
引用收藏
分享

摘要

Clear cell renal cell carcinoma (ccRCC) are typically situated in a complex inflammatory and immune microenvironment, which has been reported to contribute to the unfavorable prognosis of patients with ccRCC. There would be beneficial clinical implications for elucidating the roles of its molecular characteristics in the inflammatory microenvironment. This is because it would facilitate the development of reliable biomarkers for pre-stratification prior to the designation of individualized treatment strategies. In the present study, RNA-sequencing data from 607 patients were retrospectively analyzed to elucidate the profile of inflammatory molecules. Based on this, an inflammatory prognostic signature (IPS) was developed and further validated using clinical ccRCC samples. Subsequently, the associated mechanisms in terms of the immune microenvironment and molecular pathways were then investigated. This proposed IPS was found to exhibit superior accuracy compared with the criterion of a good prognostic model for the prediction of patient prognosis from ccRCC [area under the receiver operating characteristic curve (AUC)=0.811] in addition to being an independent factor for prognostic risk stratification [hazard ratio: 11.73 (95% CI, 26.98-5.10); log-rank test, P<0.001]. Pathologically, ccRCC cells identified as high-risk according to their IPS presented with a more malignant tumor structure, including voluminous eosinophilic cytoplasm, acinar/lamellar/tubular growth patterns and atypic nuclei. High-risk ccRCC also exhibited higher infiltration levels by four types of immune cells, including T regulatory cells, but lower infiltration levels by mast cells. Pathways associated with immune-inflammation interaction, including the IL-17 pathway, were found to be upregulated in IPS-identified high-risk ccRCC. Furthermore, by combining the IPS with clinical factors, an integrated prognostic index was developed and validated for increasing the accuracy of patient risk-stratification for ccRCC (AUC=0.911). In conclusion, the complex regulatory mechanisms and molecular characteristics involved in ccRCC-inflammation interaction, coupled with their prognostic potential, were systematically elucidated in the present study. This may have important implications in furthering the understanding into the molecular mechanisms underlying this ccRCC-inflammation interaction, which can in turn be exploited for identifying high-risk patients with ccRCC prior to designing their clinical treatment strategy.

学科与关键词

关键词
clear cell renal cell carcinomainflammationimmune cellsprognostic signatureprecision medicine
相关
加载中…
  • A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma
    Lin, Ming-Jie; Tang, Xiu-Xiao; Yao, Gao-Sheng; Tan, Zhi-Ping; Dai, Lei; Wang, Ying-Han; Zhu, Jiang-Quan; Xu, Quan-Hui; Mumin, Mukhtar Adan; Liang, Hui; Wang, Zhu; Deng, Qiong; Luo, Jun-Hang*; Wei, Jin-Huan*; Cao, Jia-Zheng*Frontiers in Pharmacology, 2023, 14: 1120562.
  • A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
    Liu, Hongxiang; Luo, Yong; Zhao, Shankun; Tan, Jing; Chen, Minjian; Liu, Xihai; Ye, Jianheng; Cai, Shanghua; Deng, Yulin; Li, Jinchuang; He, Huichan; Zhang, Xin*; Zhong, Weide*Frontiers in Oncology, 2023, 13: 1202151.被引 1
  • Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
    Xia, Zhi-Nan; Wu, Jing-Gen; Yao, Wen-Hao; Meng, Yu-Yang; Jian, Wen-Gang; Wang, Teng-Da; Xue, Wei; Yu, Yi-Peng; Cai, Li-Cheng; Wang, Xing-Yuan; Zhang, Peng; Li, Zhi-Yuan; Zhou, Hao; Jiang, Zhi-Cheng; Zhou, Jia-Yu; Zhang, Cheng*Scientific Reports, 2022, 12(1): 10973.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Oncology Letters
发表日期
2022-09
卷期
第 24 卷, 第 3 期
页码
307
DOI
10.3892/ol.2022.13427
语言
ENGLISH
期刊等级
4区
成果收录
SCIE

作者

  • L

    Liu, Gangcheng (第一作者)

    2 · china three gorges univ

  • X

    Xiong, Donglan

    2 · three gorges univ

查看全部 5 位作者收起作者
  • C

    Che, Zhifei

    1 · hainan med univ

  • C

    Chen, Hualei (通讯)

    2 · hainan med univ

  • J

    Jin, Wenyi (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417